Gilead Sciences settles Texas Medicaid kickback lawsuit for $45 million
On October 22, 2026 Gilead Sciences reached a settlement with the Texas Attorney General’s office and the State of Texas to resolve a lawsuit alleging illegal kickbacks that influenced Medicaid prescriptions. The company will pay $45 million, including legal fees, and the case will be dismissed with prejudice. Gilead denied any wrongdoing but agreed to settle to avoid the cost and distraction of continued litigation.
Why it matters
The $45 million cash outflow adds a one‑time expense and highlights regulatory risk for the company, which could affect future earnings and investor sentiment. The settlement does not include an admission of liability, but it may signal heightened scrutiny of Gilead’s patient‑support programs.
Key facts
- 1Gilead Sciences agreed to pay $45 million to settle the Texas Medicaid lawsuit. marketscreener.com
- 2The settlement amount of $45 million was also reported by other sources. gurufocus.com
- 3The agreement was reached on October 22, 2026. marketscreener.com
- 4The settlement resolves allegations that Gilead provided illegal kickbacks to influence Medicaid prescriptions. gurufocus.com
- 5The case will be dismissed with prejudice and all claims released by the State of Texas and Health Choice Advocates. marketscreener.com
- 6Gilead expressly denied the allegations but settled to avoid prolonged litigation costs. marketscreener.com
Summary written by AlphAI AI Desk from 4 of 4 sources. Not investment advice. Figures are as stated by the linked sources.